Association of c.802C>T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients

Experimental and Molecular Pathology

Volumn 88, Issue 3, 2010, Pages 388-393

  Hnatyszyn, Andrzej ^a,b   Szalata, Marlena ^c,d   Stanczyk, Jerzy ^e   Cichy, Wojciech ^f   Slomski, Ryszard ^c,d  

^a District Hospital   (Poland)

^b Independent Public Hospital   (Poland)

^c INSTITUTE OF HUMAN GENETICS   (Poland)

^d POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^e Regional Hospital   (Poland)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chronic gastritis; Dysplasia; H. pylori; Intestinal type of gastric cancer; NOD2 CARD15 gene

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; NOD2 PROTEIN, HUMAN; PRIMER DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHRONIC GASTRITIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STOMACH CANCER; CASE CONTROL STUDY; CHILD; GASTRITIS; GASTROSCOPY; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER PYLORI; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH MUCOSA; STOMACH TUMOR;

HELICOBACTER PYLORI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; DNA PRIMERS; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 77952557774     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.03.003     Document Type: Article

References (38)

1. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
2. Chamaillard M., Hashimoto M., Horie Y., et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003, 4:702-707.
3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992, 52:6735-6740.
4. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996, 20:1161-1181.
5. Dobrowolska-Zachwieja A., Kaczmarek M., Hoppe-Golebiewska J., et al. Does the presence of NOD2/CARD 15 mutations influence the incidence of extraintestinal manifestations in patients with Crohn's disease?. Gastroenterol. Pol. 2005, 12:393-400.
6. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
7. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193-1201.
8. Forman D., Newell D.G., Fullerton F., et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Brit. Med. J. 1991, 302:1302-1305.
9. Graham D.Y., Malaty H.M., Evans D.G., et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991, 100:1495-1501.
10. Helicobacter and Cancer Collaborative Group Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001, 49:347-353.
11. Hirai I., Sasaki T., Kimoto A., et al. Assessment of East Asian-type cagA-positive Helicobacter pylori using stool specimens from asymptomatic healthy Japanese individuals. J. Med. Microbiol. 2009, 58:1149-1153.
12. Hiyama T., Tanaka S., Kitadai Y., et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int. J. Cancer 2002, 100:304-308.
13. Hnatyszyn A., Kalak R., Kaczmarek M., et al. Molecular analysis of NOD2/CARD15 and TP53 genes in H. pylori-infected patients with chronic gastritis, intestinal metaplasia and dysplasia, and intestinal type of gastric cancer. Can. J. Gastroenterol. 2005, 19:17B.
14. International Agency for Research on Cancer, 1994. Schistosomes, liver flukes and Helicobacter pylori, in: IARC (Eds.), IARC monographs on the evaluation of carcinogenic risks to humans. IARC Lyon, France, 61, pp. 177-220.
15. Isomoto H., Mizuta Y., Miyazaki M., et al. Implication of NF-kappaB in Helicobacter pylori-associated gastritis. Am. J. Gastroenterol. 2000, 95:2768-2776.
16. Juyal G., Amre D., Midha V., et al. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians. Aliment. Pharmacol. Ther. 2007, 26:1325-1332.
17. Keates S., Hitti Y.S., Upton M., et al. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 1997, 113:1099-1109.
18. Keates S., Keates A.C., Warny M., et al. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J. Immunol. 1999, 163:5552-5559.
19. Kim N. Epidemiology and transmission route of Helicobacter pylori infection. Korean J. Gastroenterol. 2005, 46(3):153-158.
20. Kurzawski G., Suchy J., Kładny J., et al. The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res. 2004, 64:1604-1606.
21. Kustmann E., Epplen C., Elitok E., et al. Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis 1999, 20:1756-1761.
22. Machado J.C., Figueiredo C., Canedo P., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003, 125:364-371.
23. Mori N., Ueda A., Geleziunas R., et al. Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB. Infect. Immun. 2001, 69:1280-1286.
24. Nagy Z., Karádi O., Rumi G., et al. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Ann. N. Y. Acad. Sci. 2005, 1051:45-51.
25. Nardone G., Staibano S., Rocco A., et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999, 44:789-799.
26. Naumann M., Wessler S., Bartsch C., et al. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem. 1999, 274:31655-31662.
27. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
28. Ogura Y., Inohara N., Benito A., et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 2001, 276:4812-4818.
29. Papaconstantinou I., Theodoropoulos G., Gazouli M., et al. Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int. J. Cancer 2005, 114:433-435.
30. Peek R.M. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G525-G530.
31. Rosenstiel P., Hellmig S., Hampe J., et al. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell. Microbiol. 2006, 8:1188-1198.
32. The Eurogast Study Group An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993, 341:1359-1362.
33. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001, 345:784-789.
34. Warren J.R., Marshall B. Unidentified curved bacilli on gastric epithelium in active gastritis. Lancet 1983, 1:1273-1275.
35. Williams M.P., Pounder R.E. Helicobacter pylori: from the benign to the malignant. Am. J. Gastroenterol. 1999, 94:S11-S16.
36. Wong B.C., Lam S.K., Wong W.M., et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004, 291:187-194.
37. Working Party Report to the World Congresses of Gastroenterology Sydney 1990. J. Gastroenterol. Hepatol. 1991, 67:207-252.
38. Yim J.Y., Kim N., Choi S.H., et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007, 12(4):333-340.